SCHEMBL14059686

SCHEMBL14059686

Clc1ccc(Cl)c(-c2nc(-c3ccsc3)[nH]c2-c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.50
MAPK12 P53778 10/20 0.50
MAPK11 Q15759 10/20 0.50
MAPK14 Q16539 10/20 0.50
RAF1 P04049 7/20 0.50
GCGR P47871 4/20 0.48
BRAF P15056 3/20 0.47
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
MAPK9 P45984 1/20 0.43
NPY5R Q15761 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
FTO Q9C0B1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31305542 1.00 MAPK13 (0.50) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060795 0.91 MAPK13 (0.50) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL31305528 0.91 MAPK13 (0.50) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL31305575 0.88 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060614 0.88 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL28406403 0.84 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060675 0.84 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060485 0.84 MAPK13 (0.69) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060772 0.83 MAPK13 (0.71) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14060694 0.83 MAPK13 (0.70) MAPK13MAPK12MAPK11MAPK14RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4506488-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY Shikoku Chemicals Corporation (JP) 2025-02-12 EP disclosed
WO-2023190263-A1 SURFACE TREATMENT AGENT FOR COPPER OR COPPER ALLOY 四国化成工業株式会社 2023-10-05 WO disclosed
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2019-08-27 US disclosed
US-20170064823-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2017-03-02 US disclosed
US-9532493-B2 Surface treating composition for copper and copper alloy and utilization thereof SHIKOKU CHEMICALS CORPORATION (JP) 2016-12-27 US disclosed
EP-2714962-B1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEM (JP) 2015-07-08 EP disclosed
US-20140097231-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2014-04-10 US disclosed
CN-103547706-A Surface treatment composition for copper and copper alloy and use thereof SHIKOKU CHEM 2014-01-29 CN disclosed
WO-2012161341-A1 SURFACE TREATING COMPOSITION FOR COPPER AND COPPER ALLOY AND UTILIZATION THEREOF SHIKOKU CHEMICALS CORPORATION (JP) 2012-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10398028-B2 Surface treating composition for copper and copper alloy and utilization thereof SOD1, SOD3, AOC3 MAPK13 1347/4885MAPK12 1599/4885MAPK11 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.